Could Clearing The Blurred EU Regulatory Lines For Non-Medical Brain Stimulation Devices Open Pandora’s Box?
This article was originally published in Clinica
Transcranial brain stimulation devices with non-medical claims of enhancing people’s mental acuity are coming under the scrutiny of EU regulators, ahead of the adoption of the new Medical Device Regulation.
You may also be interested in...
Updated medtech notified body figures from the European Commission always make headline news. But industry needs to see real appointments now, not a list of tricky-to-understand numbers.
Erik Hansson remains deputy head of devices in a move to the European Commission’s DG Sante from DG Grow. He now answers to a newly appointed devices head who shares a common educational background but whose recent pharmaceutical role may unsettle the devices industry.
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?